Rakoczy Molino Mazzochi Siwik LLP
We are only able to display limited information for this firm. We display more complete information for all of the following firms:
Chicago-based boutique firm Rakoczy Molino Mazzochi Siwik LLP is highly regarded for its strong litigation capabilities in the biopharma sector. The team represents a broad array of pharma and biopharma generic drugs in high-stakes patent litigation against brand-name drug owners in Hatch-Waxman cases. The practice is co-chaired by managing partners Paul Molino and William Rakoczy. Molino boasts a strong track record at the Court of Appeals for biosimilars and biologics, while Rakoczy is recognized as ‘one of the best trial attorneys’ in Hatch-Waxman and BPCIA litigation. Other key practitioners specializing in Hatch-Waxman proceedings include Deanne Mazzochi, Kevin Warner and Rachel Pernic Waldron. Lara FitzSimmons combines her expertise in Hatch-Waxman proceedings with her background in life sciences transactions. Eric Hunt has further strengthened the team with his expertise in biosimilars, particularly for start-up companies.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘RMMS has a soup-to-nuts setup with fantastic science advisors for FTO work, transactions counsel for licensing and settlement work, FDA regulatory counsel to advise during litigation, and patent litigators and trial attorneys focused on generics and biosimilar litigation.’
- ‘William Rakoczy is one of the best trial attorneys in Hatch-Waxman and BPCIA litigation. Lara Fitzsimmons is a tremendous life sciences transactional specialist.’
Key clients
- KD Pharma Group Sandoz Lupin Apotex Mylan/Viatris Innova Softgel LLC Dr. Reddy’s Laboratories Designs for Health Baxter Healthcare Corporation Padagis Biocon Biologics Inc. Alkem Laboratories Ltd. Glenmark Pharmaceuticals Alembic Pharmaceuticals Fresenius Kabi FieldTurf USA, Inc. / Tarkett Sports Canada, Inc. MSN Pharmaceuticals, Inc. Natco Pharma Limited Aveva Drug Delivery Systems, Inc. Novugen Tolmar, Inc.
Work highlights
Secured non-infringement win on behalf of client, Aveva Drug Delivery Systems, Inc., in connection with litigation involving Scilex Pharmaceuticals Inc.’s, ITOCHU CHEMICAL FRONTIER Corporation’s, and Oishi Koseido Co., Ltd.’s post-herpetic neuralgia drug,ZTLido® (lidocaine topical system) 1.8%.